ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,865, issued on Jan. 20, was assigned to NantCell Inc. (Culver City, Calif.).
"haNK cetuximab combinations and methods" was invented by Patrick Soon-Shiong (Culver City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Contemplated cancer therapies comprise co-administration of aldoxorubicin with an immune therapeutic composition that preferably comprises a vaccine component and a cytotoxic cell component."
The patent was filed on Sept. 1, 2022, under Application No. 17/901,391.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%...